Skip to main content
Log in

Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies

  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Over the past decade, genetically engineered mouse models have been used for studies of the mechanisms underlying human diseases. One advantage of these models is that the targeted protein executes its function in normal cells in their natural tissue microenvironments. Transgenic mouse models for human viral hepatitis have also been established and have provided new insights into the pathogenesis of hepatitis and hepatocellular carcinoma (HCC). In the search for the mechanism of hepatocarcinogenesis in hepatitis viral infection, two viral proteins, the core protein of hepatitis C virus (HCV) and the HBx protein of hepatitis B virus (HBV), have been shown to possess oncogenic potential through transgenic mouse studies, indicating the direct involvement of the hepatitis viruses in hepatocarcinogenesis. The presence of the hepatitis C virus core or HBx protein, which has an oncogenic potential, may allow some of the steps in multistep hepatocarcinogenesis to be skipped. This may explain the very high frequency of HCC in patients with HCV or HBV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beasley RP, Hwang L-Y. Epidemiology of hepatocellular carci noma. In: Vyas GN, Dienstag JL, Hoofnagle JH, editions. Viral hepatitis and liver disease. Orlando: Grune and Stratton; 1984. p. 209–24.

    Google Scholar 

  2. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547–9.

    Article  PubMed  CAS  Google Scholar 

  3. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detec tion of antibody to hepatitis C virus. Hepatology 1990;12:671–5.

    Article  PubMed  CAS  Google Scholar 

  4. Chisari FV. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology 1995;22:1316–25.

    PubMed  CAS  Google Scholar 

  5. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359–62.

    Article  PubMed  CAS  Google Scholar 

  6. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of hepatitis C viruses. Implications for diagnosis, develop ment and control of viral diseases. Hepatology 1991;14:381–8.

    PubMed  CAS  Google Scholar 

  7. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992;116:97–102.

    PubMed  CAS  Google Scholar 

  8. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362–4.

    Article  PubMed  CAS  Google Scholar 

  9. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Re view of extrahepatic manifestations. Ann Intern Med 1995;123: 615–20.

    PubMed  CAS  Google Scholar 

  10. Cacoub P, Poynard T, Giuliani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999;42:2204–12.

    Article  PubMed  CAS  Google Scholar 

  11. Mariette X. The hepatitis C virus and systemic diseases. Rev Rhum Engl Ed 1998;65:737–40.

    PubMed  CAS  Google Scholar 

  12. Lerat H, Loesch K, Honda M, Gozert R, Ping LH, West AB, et al. Transgenic mice expressing HCV proteins develop micro vesicular steatosis and hepatocellular carcinoma. Proceedings of 6th International Symposium on Hepatitis C and Related Viruses; 1999. p. 199.

  13. Matsuda J, Suzuki M, Nozaki C, Shinya N, Tashiro K, Mizuno K, et al. Transgenic mouse expressing a full-length hepatitis C virus cDNA. Jpn J Cancer Res 1998;89:150–8.

    PubMed  CAS  Google Scholar 

  14. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997;78:1527–31.

    PubMed  CAS  Google Scholar 

  15. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, et al. Hepatitis C virus core protein induces hepato cellular carcinoma in transgenic mice. Nature Med 1998;4:1065–8.

    Article  PubMed  CAS  Google Scholar 

  16. Pasquinelli C, Shoenberger JM, Chung J, Chang KM, Guidotti LG, Selby M, et al. Hepatitis C virus core and E2 protein expres sion in transgenic mice. Hepatology 1997;25:719–27.

    Article  PubMed  CAS  Google Scholar 

  17. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76:3031–8.

    Article  PubMed  CAS  Google Scholar 

  18. Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC, Schmidt EV, et al. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 1997;25:1014–21.

    Article  PubMed  CAS  Google Scholar 

  19. Wakita T, Taya C, Katsume A, Kato J, Yonekawa H, Kanegae Y, et al. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem 1998;273:9001–6.

    Article  PubMed  CAS  Google Scholar 

  20. Shintani Y, Moriya K, Fujie H, Tsutsumi T, Ishibashi K, Matsuura Y, et al. Establishment and analysis of transgenic mice carrying the non-structural region of hepatitis C virus. Proceedings of 6th International Symposium on Hepatitis C and Related Viruses; 1999. p. 162.

  21. Hino O, Kajino K. Hepatitis virus-related hepatocarcinogenesis. Intervirology 1994;37:133–5.

    PubMed  CAS  Google Scholar 

  22. Takeuchi K, Kubo Y, Boonmer S, Watanabe Y, Katayama T, Choo QL, et al. The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucle otide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol 1990;71:3027–33.

    Article  PubMed  CAS  Google Scholar 

  23. Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H, et al. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A 1997;94:233–6.

    Article  PubMed  CAS  Google Scholar 

  24. Koike K, Moriya K, lino S, Yotsuyanagi H, Endo Y, Miyamura T, et al. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994;19:. 810–9.

    Article  PubMed  CAS  Google Scholar 

  25. Smith GS, Walford RL, Mickey MR. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J Natl Cancer Inst 1973;50:1195–213.

    PubMed  CAS  Google Scholar 

  26. Nakamura K, Kuramoto K, Shibasaki K, Sumiya S, Ohtsubo K. Age-related incidence of spontaneous tumors in SPF C57BL/6 and BDF1 mice. Exp Anim 1992;41:279–85.

    CAS  Google Scholar 

  27. Caporaso N, Romano M, Maromo R, de Sio I, Morisco F, Minerva A, Coltorti M. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in pa tients with cirrhosis. J Hepatol 1991:12:367–71.

    Article  PubMed  CAS  Google Scholar 

  28. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol1993;67:5823–32.

    PubMed  CAS  Google Scholar 

  29. Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985;230:1157–60.

    Article  PubMed  CAS  Google Scholar 

  30. Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 1985;230:1160–3.

    Article  PubMed  CAS  Google Scholar 

  31. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, et al. Molecular pathogenesis of hepatocellular carci noma in hepatitis B virus transgenic mice. Cell 1989;59:1145–56.

    Article  PubMed  CAS  Google Scholar 

  32. Kim C, Koike K, Saito I, Miyamura T, Jay G. Hepatitis B virus HBx gene induces liver cancer in transgenic mice. Nature 1991;351:317–20.

    Article  PubMed  CAS  Google Scholar 

  33. Yu DY, Moon HB, Son JK, Jeong S, Jeong S, Yu SL, et al. Incidence of hepatocellular carcinoma in transgenic mice express ing the hepatitis B virus X-protein. J Hepatol 1999;31:123–32.

    Article  PubMed  CAS  Google Scholar 

  34. Farza H, Hadchouel M, Scotto J, Tiollais P, Babinet C, Pourcel C. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol 1988;62:4144–52.

    PubMed  CAS  Google Scholar 

  35. Araki K, Miyazaki J, Hino O, Tomita N, Chisaka O, Matsubara K, et al. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci U S A 1989;86:207–11.

    Article  PubMed  CAS  Google Scholar 

  36. Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepa titis B virus replication in transgenic mice. J Virol 1995;69:6158–69.

    PubMed  CAS  Google Scholar 

  37. Guidotti LG, Martinez V, Loh YT, Rogler CE, Chisari FV. Hepatitis B virus nucleocapsid particles do not cross the hepato cyte nuclear membrane in transgenic mice. J Virol 1994;68:5469–75.

    PubMed  CAS  Google Scholar 

  38. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990;87:6599–603.

    Article  PubMed  CAS  Google Scholar 

  39. Burk RD, DeLoia JA, elAwady MK, Gearhart JD. Tissue prefer ential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice. J Virol 1988;62:649–54.

    PubMed  CAS  Google Scholar 

  40. Koike K, lino S, Kurai K, Endo Y, Saito I, Miyamura T, et al. Transgenic mice carrying hepatitis B virus X gene. Hepatology 1990;12:421.

    Google Scholar 

  41. Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SL, Butel JS. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 1990;64:5939–47.

    PubMed  CAS  Google Scholar 

  42. Perfumo S, Amicone L, Colloca S, Giorgio M, Pozzi L, Tripodi M. Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice. J Virol 1992;66:6819–23.

    PubMed  CAS  Google Scholar 

  43. Balsano C, Billet O, Bennoun M, Cavard C, Zider A, Grimber G, et al. Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol 1994;21:103–9.

    Article  PubMed  CAS  Google Scholar 

  44. Billet O, Grimber G, Levrero M, Seye KA, Briand P, Joulin V. In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J Virol 1995;69:5912–6.

    PubMed  CAS  Google Scholar 

  45. Reifenberg K, Lohler J, Pudollek HP, Schmitteckert E, Spindler G, Kock J, et al. Long-term expression of the hepatitis B virus core- and X-proteins does not cause pathologic changes in transgenic mice. J Hepatol 1997;26:119–30.

    Article  PubMed  CAS  Google Scholar 

  46. Sirma H, Giannnini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Abrogation of the growth suppressive effects of wild type hepatitis B virus X protein by mutations present in hepato cellular carcinoma. San Diego: Proceedings of the Molecular biology of hepatitis B virus; 1998. p. 73.

  47. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, et al. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998;17:2115–23.

    Article  PubMed  CAS  Google Scholar 

  48. Koike K, Moriya K, Yotsuyanagi H, lino S, Kurokawa K. Induc tion of cell cycle progression by hepatitis B virus HBx gene ex pression in quiescent mouse fibroblasts. J Clin Invest 1994;94:44–9.

    Article  PubMed  CAS  Google Scholar 

  49. Koike K, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Tsutsumi T, et al. Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis. Can cer Lett 1998;134:181–6.

    Article  CAS  Google Scholar 

  50. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159–70.

    Article  PubMed  CAS  Google Scholar 

  51. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997;386:761–3.

    Article  PubMed  CAS  Google Scholar 

  52. Kew MC. Hepatitis B and C viruses and hepatocellular carci noma. Clin Lab Med 1996;16:395–406.

    PubMed  CAS  Google Scholar 

  53. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, et al. Disease progression and hepatocellular carcinogenesis in pa tients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998;28:930–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koike, K. Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. J Gastroenterol 37 (Suppl 13), 55–64 (2002). https://doi.org/10.1007/BF02990101

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02990101

Key words

Navigation